These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 12883680

  • 1. Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas.
    Su TH, Chang JG, Yeh KT, Lin TH, Lee TP, Chen JC, Lin CC.
    Oncol Rep; 2003; 10(5):1195-200. PubMed ID: 12883680
    [Abstract] [Full Text] [Related]

  • 2. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer.
    Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC, Lin CC.
    Int J Oncol; 2003 Oct; 23(4):1001-7. PubMed ID: 12963979
    [Abstract] [Full Text] [Related]

  • 3. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
    Zhou CX, Gao Y.
    Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
    [Abstract] [Full Text] [Related]

  • 4. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H, Helmchen B, Bönisch A, Aulmann S, Penzel R, Otto HF, Rieker RJ.
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [Abstract] [Full Text] [Related]

  • 5. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.
    Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
    Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sörensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T.
    Cancer Res; 2001 Oct 01; 61(19):7039-43. PubMed ID: 11585731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
    Miyake T, Tanaka Y, Kato K, Tanaka M, Sato Y, Ijiri R, Inayama Y, Ito Y, Aoki S, Kawabe R, Tohnai I.
    Pathol Int; 2006 Dec 01; 56(12):732-7. PubMed ID: 17096730
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K, Singh S, Schirmacher P, Bläker H.
    J Pathol; 2008 Jul 01; 215(3):300-7. PubMed ID: 18491352
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Axin, the main component of the Wnt signaling pathway, is not mutated in kidney tumors in children.
    Miao J, Kusafuka T, Udatsu Y, Okada A.
    Int J Mol Med; 2002 Apr 01; 9(4):377-9. PubMed ID: 11891531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.